Skip to content
Oculis logo

Oculis Alternatives & Competitors

12 companies similar to Oculis — Visionary Innovation

Companies similar to Oculis

Clearside Biomedical, Inc. logo — alternative to Oculis

Clearside Biomedical, Inc.

Revolutionizing the delivery of therapies to the back of the eye through the suprachoroida...

Novaliq GmbH logo — alternative to Oculis

Novaliq GmbH

Transforming Ocular Therapeutics

Vantage Biosciences logo — alternative to Oculis

Vantage Biosciences

Transforming diabetic eye disease with an oral treatment

FimmCyte logo — alternative to Oculis

FimmCyte

First disease modifying treatment for Endometriosis.

Rival Readout

Competing with Oculis? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Sling Therapeutics logo — alternative to Oculis

Sling Therapeutics

Focused on late-stage development of an oral small molecule for the treatment of thyroid e...

Odyssey Therapeutics logo — alternative to Oculis

Odyssey Therapeutics

Building a machine learning-based platform to develop novel therapeutics focusing on cance...

iCare logo — alternative to Oculis

iCare

Establishing the next level of eye care.

ROME Therapeutics logo — alternative to Oculis

ROME Therapeutics

Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...

Yaqrit logo — alternative to Oculis

Yaqrit

The Liver Disease Company

Phyteau, Inc. logo — alternative to Oculis

Phyteau, Inc.

Designed by Nature, Delivered by Science: A new class of incretin therapy for diabetes, ob...

Emmaus Life Sciences, Inc logo — alternative to Oculis

Emmaus Life Sciences, Inc

Improving the lives of people with rare disease.

Novoron Bioscience logo — alternative to Oculis

Novoron Bioscience

Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the...

About Oculis

Oculis, founded in 2017, is a global biopharmaceutical company, publicly listed as Nasdaq: OCS and XICE: OCS. With headquarters in Switzerland and operations in the U.S. and Iceland, the company is focused on saving sight and enhancing eye care worldwide.

Services

Development of ophthalmic and neuro-ophthalmic treatments, Innovative pipeline and clinical trials, Transformative patient-centric solutions

Target Customers

Patients with diabetic macular edema, Patients with dry eye disease, Patients with optic neuritis, Medical professionals in ophthalmology and neuro-ophthalmology

Business keywords

Biopharmaceutical Company, Ophthalmic Diseases, Drug Delivery Platform, Diabetic Macular Edema, Cataract Surgery Inflammation, Dry Eye Disease, Anterior Uveitis, Acute Optic Neuritis, Topical Eye Drops, Neuroprotection, Anti-TNFα Biologics, Non-invasive Treatments, Innovative Product Pipeline, Ophthalmology Innovation, International Healthcare Investors

Business Model

B2B, B2C, B2D

Revenue Model

Product Sales, Licensing

Frequently Asked Questions

Companies similar to Oculis include Clearside Biomedical, Inc., Novaliq GmbH, Vantage Biosciences, FimmCyte, Sling Therapeutics. They work in Biotechnology and Health Care and share Oculis's focus on diabetic macular edema and dry eye disease.
Bounce Watch lists 12 companies that share Oculis's industries and are closest to it in business tags, services, target customers, business model and size.
Oculis, founded in 2017, is a global biopharmaceutical company, publicly listed as Nasdaq: OCS and XICE: OCS. With headquarters in Switzerland and operations in the U.S. and Iceland, the company is focused on saving sight and enhancing eye care worldwide.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Oculis: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Oculis on 6 May 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout